Skip to Main Content

Chapter 19: Fragmentation Hemolytic Anemia

DEFINITION

  • Acquired erythrocyte fragmentation occurs when red cells are forced at high shear stress through partial vascular occlusions or over abnormal vascular surfaces.

  • In circumstances in which fragmentation of red cells occurs in the microcirculation, it is often referred to as microangiopathic hemolytic anemia.

  • In three primary disorders—thrombotic thrombocytopenic purpura (TTP) (Chap. 90), hemolytic uremic syndrome (HUS) (Chap. 90), and disseminated intravascular coagulation (DIC) (Chap. 85)—microangiopathic (fragmentation) hemolytic anemia is an essential diagnostic feature. These disorders are discussed in other chapters.

  • In addition to signs of hemolysis such as anemia, reticulocytosis, decreased haptoglobin, elevated indirect bilirubin, and sometimes elevated serum lactic dehydrogenase, fragmented red cells (schistocytes) are evident in the blood film (Figure 19–1). Their prevalence may vary.

  • Fragmentation hemolytic anemia syndromes discussed in this chapter include (1) hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome, (2) disseminated malignancy, (3) heart valve hemolysis, (4) march hemoglobinuria, and (5) the Kasabach-Merritt phenomenon.

FIGURE 19–1

This image shows typical appearance of fragmented red cells. Two cases of fragmentation hemolytic anemia as a result of heart valve hemolysis. The red cell shape abnormalities are varied and characteristic of fragmentation hemolysis, although they are not specific for the cause. In the normal blood film, cells that deviate significantly in form from the normal circular shape occur only once every several thousand cells. The average oil immersion field in an area suitable for examining red cell morphology contains approximately 200 red cells. In a patient with anemia, that number may be much less. Thus, even one fragmented cell per oil immersion field is notable, although not in itself diagnostic. (Reproduced with permission from Lichtman’s Atlas of Hematology, www.accessmedicine.com.)

image
View Full Size||Download Slide (.ppt)

HELLP SYNDROME

  • HELLP syndrome, a life-threatening condition of pregnancy, causes hemolysis, elevated liver function tests, and low platelets.

Etiology and Pathogenesis

  • Abnormal development of the placental vasculature causes increased vascular tone, hypertension, proteinuria, enhanced platelet activation and aggregation, and decreased levels of the vasodilators prostaglandin I2 and nitrous oxide.

  • Concurrent activation of the coagulation cascade results in platelet-fibrin deposition in the capillaries, multiorgan microvascular injury, microangiopathic (fragmentation) hemolytic anemia, elevated liver enzymes because of hepatic necrosis, and thrombocytopenia because of peripheral consumption.

  • Risk factors for HELLP syndrome include European ancestry, multiparity, advanced maternal age (> 34 years), and a personal or familial history of the disorder.

  • Homozygosity for the 677C → T polymorphism of the methylenetetrahydrofolate reductase gene is a modest risk factor for the development of preeclampsia but is not associated with the development of HELLP syndrome. Whether or not the factor V Leiden or prothrombin 20210 gene mutations are risk factors for HELLP syndrome remains controversial.

Clinical Features

  • Two thirds of patients are diagnosed antepartum, usually between 27 and ...

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.

This site uses cookies to provide, maintain and improve your experience. MHE Privacy Center Close